EMA
approval
· 2015-05-22
First-in-class treatment to lower cholesterol
Summary
EMA announces a first-in-class treatment to lower cholesterol, representing a novel mechanism for managing the condition.
Upgrade for the full analysis, importance score, and drug timeline.